However, the majority of CD4+ T cells in different tumors, including CRC, are not effector cells but predominantly T regulatory cells, expressing several IC molecules, such as PD-1, CTLA-4, TIM-3, and others [7]. This evidence concerns the gene CTLA4 and colorectal carcinoma.